Literature DB >> 20364413

The vagal immune reflex: a blessing from above.

David J van Westerloo1.   

Abstract

The innate immune response is activated upon recognition of infection or injury. A tight regulation of this inflammatory response is vital to ensure that it does not spin out of control and becomes harmful to the host. Recently, a neural circuit has been identified that controls the inflammatory response in a reflex-like manner. This circuit involves the vagus nerve which is able to sense inflammation and to respond to it by releasing acetylcholine which, through an interaction with immune cells, dampens the inflammatory response. The current knowledge regarding this "vagal immune reflex" is discussed with an emphasis on its role in sepsis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20364413     DOI: 10.1007/s10354-010-0761-x

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  32 in total

Review 1.  Vagus-nerve stimulation for the treatment of epilepsy.

Authors:  Elinor Ben-Menachem
Journal:  Lancet Neurol       Date:  2002-12       Impact factor: 44.182

Review 2.  Vagus nerve stimulation therapy: a research update.

Authors:  Mark S George; Z Nahas; D E Bohning; F A Kozel; B Anderson; J-H Chae; M Lomarev; S Denslow; X Li; C Mu
Journal:  Neurology       Date:  2002-09-24       Impact factor: 9.910

3.  Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway.

Authors:  Wouter J de Jonge; Esmerij P van der Zanden; Frans O The; Maarten F Bijlsma; David J van Westerloo; Roelof J Bennink; Hans-Rudolf Berthoud; Satoshi Uematsu; Shizuo Akira; Rene M van den Wijngaard; Guy E Boeckxstaens
Journal:  Nat Immunol       Date:  2005-07-17       Impact factor: 25.606

4.  Screening for new agonists against Alzheimer's disease.

Authors:  Huiqin Zheng; Dong-Qing Wei; Rui Zhang; Chunfang Wang; Huachun Wei; Kuo-Chen Chou
Journal:  Med Chem       Date:  2007-09       Impact factor: 2.745

5.  Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome.

Authors:  H A Sackeim; A J Rush; M S George; L B Marangell; M M Husain; Z Nahas; C R Johnson; S Seidman; C Giller; S Haines; R K Simpson; R R Goodman
Journal:  Neuropsychopharmacology       Date:  2001-11       Impact factor: 7.853

Review 6.  Vagus nerve stimulation (VNS): utility in neuropsychiatric disorders.

Authors:  Mark S George; A John Rush; Harold A Sackeim; Lauren B Marangell
Journal:  Int J Neuropsychopharmacol       Date:  2003-03       Impact factor: 5.176

7.  Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis.

Authors:  Jared M Huston; Margot Gallowitsch-Puerta; Mahendar Ochani; Kanta Ochani; Renqi Yuan; Mauricio Rosas-Ballina; Mala Ashok; Richard S Goldstein; Sangeeta Chavan; Valentin A Pavlov; Christine N Metz; Huan Yang; Christopher J Czura; Haichao Wang; Kevin J Tracey
Journal:  Crit Care Med       Date:  2007-12       Impact factor: 7.598

8.  Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung.

Authors:  Ida A J Giebelen; David J van Westerloo; Gregory J LaRosa; Alex F de Vos; Tom van der Poll
Journal:  Shock       Date:  2007-12       Impact factor: 3.454

Review 9.  Reflex control of immunity.

Authors:  Kevin J Tracey
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

10.  Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.

Authors:  Hong Wang; Man Yu; Mahendar Ochani; Carol Ann Amella; Mahira Tanovic; Seenu Susarla; Jian Hua Li; Haichao Wang; Huan Yang; Luis Ulloa; Yousef Al-Abed; Christopher J Czura; Kevin J Tracey
Journal:  Nature       Date:  2002-12-22       Impact factor: 49.962

View more
  11 in total

1.  Editorial: sepsis.

Authors:  Sylvia Knapp; Michael Frass
Journal:  Wien Med Wochenschr       Date:  2010-03

Review 2.  Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.

Authors:  Merouane Bencherif; Patrick M Lippiello; Rudolf Lucas; Mario B Marrero
Journal:  Cell Mol Life Sci       Date:  2010-10-15       Impact factor: 9.261

3.  Influence of vagal injury on acute traumatic reaction after blast injury.

Authors:  Y Wang; L Pan; W Fan; Z Zhou; L Zhu; Y Wang; R Hu
Journal:  Eur J Trauma Emerg Surg       Date:  2013-04-03       Impact factor: 3.693

4.  Berberine relieves insulin resistance via the cholinergic anti-inflammatory pathway in HepG2 cells.

Authors:  Fen Li; Yun-Bin Zhao; Ding-Kun Wang; Xin Zou; Ke Fang; Kai-Fu Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-02-03

Review 5.  The spinal cord-gut-immune axis as a master regulator of health and neurological function after spinal cord injury.

Authors:  Kristina A Kigerl; Kylie Zane; Kia Adams; Matthew B Sullivan; Phillip G Popovich
Journal:  Exp Neurol       Date:  2019-10-22       Impact factor: 5.330

6.  Neural pathways in allergic inflammation.

Authors:  L Mirotti; J Castro; F A Costa-Pinto; M Russo
Journal:  J Allergy (Cairo)       Date:  2011-02-09

Review 7.  The effect of light on critical illness.

Authors:  Ricardo Castro; Derek C Angus; Matt R Rosengart
Journal:  Crit Care       Date:  2011-03-22       Impact factor: 9.097

Review 8.  Sensorineural Tinnitus: Its Pathology and Probable Therapies.

Authors:  Aage R Møller
Journal:  Int J Otolaryngol       Date:  2016-02-08

9.  Short-Term High-Fat Diet Consumption Reduces Hypothalamic Expression of the Nicotinic Acetylcholine Receptor α7 Subunit (α7nAChR) and Affects the Anti-inflammatory Response in a Mouse Model of Sepsis.

Authors:  Anelise Cristina Parras Souza; Camilla Mendes Souza; Camila Libardi Amaral; Simone Ferreira Lemes; Leticia Foglia Santucci; Marciane Milanski; Adriana Souza Torsoni; Marcio Alberto Torsoni
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

Review 10.  Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection.

Authors:  Júlia Leão Batista Simões; Julia Beatrice de Araújo; Margarete Dulce Bagatini
Journal:  Mol Neurobiol       Date:  2021-07-11       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.